NHS leaders in England have warned that the costs linked to ADHD and autism are now “out of control,” according to a new report highlighted by The BMJ. The warning comes as health services continue to face growing pressure from demand for assessment, treatment and support, with the issue emerging as one of the latest flashpoints in the debate over how the NHS manages neurodevelopmental care.
The BMJ reported the warning on September 1, 2026, alongside a series of other health stories focused on current pressures across the UK system. That context matters: the latest reporting suggests that services are being asked to do more at a time when staff and resources are already stretched, and leaders are concerned that the current trajectory is unsustainable.
Growing demand is putting new strain on services
The report does not just point to rising costs, but to the wider impact on NHS capacity. Increased demand for ADHD and autism-related care can affect appointments, waiting times and the ability of clinicians to respond quickly to patients with other needs. For health leaders, the concern is not only financial but operational, with the pressure feeding into a system already dealing with multiple competing priorities.
The BMJ’s news coverage on the same day also showed how broad the pressure on services remains, with stories on heat-related emergency department visits, falling childhood vaccination rates in babies, and concerns about GP AI receptionists failing to understand some patients with accents. Taken together, the reporting paints a picture of an NHS balancing rising demand, technology challenges and uneven access to care.
Why the warning matters for patients and clinicians
ADHD and autism diagnoses have become a major policy and service issue in the UK, with families often seeking support not just for assessment, but for long-term adjustments in education, work and daily life. When leaders describe the costs as being out of control, it signals that the current system is struggling to keep pace with the number of people seeking help and the complexity of the support they need. That warning is especially significant in England, where NHS planning and access to specialist services remain under intense scrutiny.
At the same time, the story reflects a broader challenge for the health service: demand is rising across many areas, while the NHS is still trying to stabilise staffing, reduce delays and improve continuity of care. In that environment, any rapidly growing service line can become a pressure point, and ADHD and autism are now firmly part of that national conversation.
What happens next
For now, the warning from NHS leaders underlines the need for a clearer plan on how neurodevelopmental services will be funded and delivered. The debate is likely to continue as policymakers weigh the needs of patients against the realities of constrained NHS budgets. What is clear from the latest reporting is that this is no longer a niche issue: it is now one of the central pressures facing health services in England.
Photo source: AI-generated or edited image
